zoledronic acid has been researched along with Cholera Infantum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadarette, SM; Juurlink, DN; Krahn, MD; Lévesque, LE; Mamdani, MM; Tadrous, M; Wong, L | 1 |
Bauer, JS; Beck, N; Eitner, S; Kiefer, J; Stockmann, P; Wichmann, M | 1 |
1 review(s) available for zoledronic acid and Cholera Infantum
Article | Year |
---|---|
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
Topics: Bone Density Conservation Agents; Diphosphonates; Gastrointestinal Diseases; Humans; Imidazoles; Nausea; Osteoporosis; Randomized Controlled Trials as Topic; Zoledronic Acid | 2014 |
1 other study(ies) available for zoledronic acid and Cholera Infantum
Article | Year |
---|---|
Awareness and education of patients receiving bisphosphonates.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Arthralgia; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Dental Care; Dentist-Patient Relations; Dentists; Diphosphonates; Drug Labeling; Female; Gastrointestinal Diseases; Health Knowledge, Attitudes, Practice; Health Literacy; Humans; Imidazoles; Injections, Intravenous; Interprofessional Relations; Male; Middle Aged; Osteoporosis; Patient Education as Topic; Physician-Patient Relations; Physicians; Prostatic Neoplasms; Risk Factors; Zoledronic Acid | 2012 |